The results revealed that the induced sputum IL-8 level and the PaCO2 decreased significantly, while the induced sputum IL-10 level, FEV1%pred, FEV1/FVC and the PaO2 increased significantly in the three groups with COPD following treatment, compared with the levels measured pre-therapy. The gene discussed is IL10; the disease is chronic obstructive pulmonary disease.